Hemangiosarcoma Research Progresses
Research paper recently published in BMC Veterinary Research keeps scientist on track to diagnosing and treating “silent killer” in canines
Chromatin run-on sequencing analysis finds that ECM remodeling plays an important role in canine hemangiosarcoma pathogenesis, a research paper recently published in BMC Veterinary Research keeps scientist on track to diagnosing and treating “silent killer” in canines.
Splenic hemangiosarcoma is an aggressive vascular tumor that is often called a “silent killer” because dog owners usually do not realize that there is a problem until the tumor has ruptured internally and spread. There is an urgent need to develop new, more effective evidence-based diagnostic tools and therapies in order to catch this tumor at an earlier stage and provide better treatment options. In this paper, the Coonrod lab at the Baker Institute for Animal Health, part of the College of Veterinary Medicine at Cornell University, took a genome-wide Chro-Seq approach to better understand the molecular pathogenesis of this lethal disease so that they can identify novel tumor-specific molecules that can be developed as biomarkers and therapeutic targets. It was discovered that remodeling of extracellular matrix plays a key role in the pathogenesis of this disease, and researchers are in the process of now further validating and testing candidate molecules that have come out of their screen.
This project would not have been possible without a great team of dedicated scientists from the Baker Institute, CUHA, Tohoku University in Japan and the generous support of Baker Institute donors.
“It is my great honor to be a part of this team, and I feel so fortunate that the Baker Institute environment/community/people support research that is aimed at improving the lives of our pets,” states Chinatsu Mukai, research associate in the Coonrod Lab and first author on the paper.
(left to right: Team from the Coonrod lab including first author of hte paper Chinatsu Mukai,
Research Associate; Kelly Sams, Lab Manager; Brooke Marks, Graduate Student.)